Oct
2026
Fiera Milano, Italy
Visit us
stand 5F34, Integrated Pharma

OMGENE LIFE SCIENCES PRIVATE LIMITED

Exhibitor at CPHI Milan 2026
About Us

Omgene Life Sciences Pvt. Ltd., the R&D based Company, incorporated in March 2011 and is operating in Bio pharmaceutical space since it’s foundation. Omgene was established by a highly skilled and experienced pharmaceutical Technocrat, Dr. A.L. Prasad (Managing Director), having around 30 years of industrial track-record, is leading the R&D team comprising 100+ highly skilled workforce. Omgene is a fast-growing Indian company engaged in developing, manufacturing, and marketing of Peptide, Oligonucleotides, Semi-synthetic & Synthetic API and recombinant molecules.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2020
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Generic APIs producer
View company profile
Contact info
  • +91 90995 05299
  • 333/334, GIDC Makarpura,, Makarpura GIDC, Vadodara, 390010, Gujarat, India
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 5F34, Integrated Pharma

Products Featured at CPHI Milan 2026

  • Complex Semi-synthetic APIs

    Product Complex Semi-synthetic APIs

    Micafungin Sodium, Anidulafungin-Fructose, Dalbavancin, Everolimus, Sarecycline, Midostaurin etc.
  • Omadacycline

    Product Omadacycline

    A tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms (1): Community-acquired bacterial pneumonia (CABP) (1.1); Acute bacterial skin and skin structure infections (ABSSSI) 
  • Rezafungin

    Product Rezafungin

    Rezafungin is a next-generation, semi-synthetic, cyclic lipopeptide and echinocandin derivative, with potential antifungal activity. 
  • Tirzepatide

    Product Tirzepatide

    Glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

  • Cetrorelix Acetate

    Product Cetrorelix Acetate

    Indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.